Oncology & Cancer

Risk of psoriasis increased for cancer survivors

(HealthDay)—Cancer survivors, especially survivors of hematologic malignancies, have an increased risk for psoriasis, according to a research letter published online June 30 in the British Journal of Dermatology.

Immunology

Questionnaire responses about dermatology history inconsistent

(HealthDay)—Asking people about a history of psoriasis may be useful for assessing psoriasis prevalence, but a similar questionnaire assessing atopic dermatitis does not appear to be as reliable of a method, according to ...

Arthritis & Rheumatism

Adults with psoriasis more likely to have rheumatoid arthritis

(HealthDay)—Adults with psoriasis have an increased likelihood of having rheumatoid arthritis (RA) compared with adults without psoriasis, according to a study published online June 15 in the Journal of the American Academy ...

Inflammatory disorders

Higher BMI linked to increased risk for developing psoriasis

(HealthDay)—Higher body mass index (BMI) seems to be associated with an increased risk for developing psoriasis, according to a study published online June 9 in the Journal of the American Academy of Dermatology.

Inflammatory disorders

Risk for autoimmunity up with concomitant vitiligo, psoriasis

(HealthDay)—Individuals with co-occurrence of vitiligo and psoriasis have an increased risk for autoimmunity and family history of psoriasis, according to a research letter published online May 20 in the Journal of the ...

Inflammatory disorders

Baseline patient characteristics may predict psoriasis course

(HealthDay)—Patient characteristics at onset can help to estimate the long-term course of psoriasis with good discriminatory power, according to a study published online April 14 in JAMA Dermatology.

Medications

New drug is gamechanger in psoriasis treatment

A novel drug almost entirely cleared moderate to severe psoriasis in over 60% of the patients who took part in two phase three clinical trials of a new drug.

page 10 from 37